IRIS Accounts Production v24.2.0.383 07146069 Board of Directors Board of Directors Board of Directors Board of Directors Board of Directors 1.5.23 30.4.24 30.4.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh071460692023-04-30071460692024-04-30071460692023-05-012024-04-30071460692022-04-30071460692022-05-012023-04-30071460692023-04-3007146069ns15:EnglandWales2023-05-012024-04-3007146069ns14:PoundSterling2023-05-012024-04-3007146069ns10:Director12023-05-012024-04-3007146069ns10:Director22023-05-012024-04-3007146069ns10:Director32023-05-012024-04-3007146069ns10:Director42023-05-012024-04-3007146069ns10:Director52023-05-012024-04-3007146069ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3007146069ns10:SmallEntities2023-05-012024-04-3007146069ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3007146069ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3007146069ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3007146069ns10:FullAccounts2023-05-012024-04-3007146069ns10:RegisteredOffice2023-05-012024-04-3007146069ns5:CurrentFinancialInstruments2024-04-3007146069ns5:CurrentFinancialInstruments2023-04-3007146069ns5:ShareCapital2024-04-3007146069ns5:ShareCapital2023-04-3007146069ns5:RetainedEarningsAccumulatedLosses2024-04-3007146069ns5:RetainedEarningsAccumulatedLosses2023-04-3007146069ns5:FurnitureFittings2023-05-012024-04-3007146069ns5:ComputerEquipment2023-05-012024-04-3007146069ns5:LandBuildingsns5:ShortLeaseholdAssets2023-04-3007146069ns5:FurnitureFittings2023-04-3007146069ns5:ComputerEquipment2023-04-3007146069ns5:LandBuildingsns5:ShortLeaseholdAssets2023-05-012024-04-3007146069ns5:LandBuildingsns5:ShortLeaseholdAssets2024-04-3007146069ns5:FurnitureFittings2024-04-3007146069ns5:ComputerEquipment2024-04-3007146069ns5:LandBuildingsns5:ShortLeaseholdAssets2023-04-3007146069ns5:FurnitureFittings2023-04-3007146069ns5:ComputerEquipment2023-04-3007146069ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3007146069ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30
REGISTERED NUMBER: 07146069 (England and Wales)












Unaudited Financial Statements

for the Year Ended 30 April 2024

for

Medical Defence Shield Limited

Medical Defence Shield Limited (Registered number: 07146069)






Contents of the Financial Statements
for the Year Ended 30 April 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Medical Defence Shield Limited

Company Information
for the Year Ended 30 April 2024







DIRECTORS: Dr A M Deshpande
Dr S M Mathew
Dr R D Mehta
Suraj Medical Consultants Limited
Dr J Grover





REGISTERED OFFICE: The Chapel
Trinity Gardens
9-11 Bromham Road
Bedford
MK40 2BP





REGISTERED NUMBER: 07146069 (England and Wales)





ACCOUNTANTS: Wormald & Partners
Chartered Accountants (ICAEW)
Brunel House
11 The Promenade
Clifton Down
Bristol
BS8 3NG

Medical Defence Shield Limited (Registered number: 07146069)

Balance Sheet
30 April 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 25,121 11,912

CURRENT ASSETS
Debtors 5 148,663 129,521
Cash at bank and in hand 35,771 119,487
184,434 249,008
CREDITORS
Amounts falling due within one year 6 237,615 100,052
NET CURRENT (LIABILITIES)/ASSETS (53,181 ) 148,956
TOTAL ASSETS LESS CURRENT
LIABILITIES

(28,060

)

160,868

CAPITAL AND RESERVES
Called up share capital 244,511 244,511
Retained earnings (272,571 ) (83,643 )
(28,060 ) 160,868

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Medical Defence Shield Limited (Registered number: 07146069)

Balance Sheet - continued
30 April 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 January 2025 and were signed on its behalf by:




Suraj Medical Consultants Limited - Director Dr A M Deshpande - Director




Dr S M Mathew - Director Dr R D Mehta - Director




Dr J Grover - Director


Medical Defence Shield Limited (Registered number: 07146069)

Notes to the Financial Statements
for the Year Ended 30 April 2024

1. STATUTORY INFORMATION

Medical Defence Shield Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance basis
Computer equipment - 25% on reducing balance basis

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 24 (2023 - 18 ) .

Medical Defence Shield Limited (Registered number: 07146069)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

4. TANGIBLE FIXED ASSETS
Fixtures
Short and Computer
leasehold fittings equipment Totals
£    £    £    £   
COST
At 1 May 2023 303 7,711 26,411 34,425
Additions - - 20,762 20,762
At 30 April 2024 303 7,711 47,173 55,187
DEPRECIATION
At 1 May 2023 - 5,837 16,676 22,513
Charge for year - 437 7,116 7,553
At 30 April 2024 - 6,274 23,792 30,066
NET BOOK VALUE
At 30 April 2024 303 1,437 23,381 25,121
At 30 April 2023 303 1,874 9,735 11,912

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 94,173 85,127
Other debtors 15,159 15,159
Prepayments and accrued income 39,331 29,235
148,663 129,521

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 81,603 -
Social security and other taxes 21,335 25,271
Other creditors 124,330 64,619
Accruals and deferred income 10,347 10,162
237,615 100,052

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

During the year the company incurred costs of £72,256 (2023 £55,000) from Suraj Medical Consultants Limited. Included within other creditors is amount due to Suraj Medical Consultants Limited in the sum of £124,330 (2023 £64,619).

Suraj Medical Consultants Limited is a corporate director and shareholder of the company.

All of the above transactions were carried out on an arms length basis.

8. ULTIMATE CONTROLLING PARTY

There is no controlling or ultimate controlling party of the company.